Published by
Contact Sara or Dan
ABA LawBlawg 100 Winner (2015)
-
Recent Posts
- Investigating the Investigators: Highlights from Recent DOJ OIG Investigations
- Rule 17(c) Subpoenas – The Unfair Limits on a Defendant’s Ability to Prepare a Defense (Part I)
- What Is A Joint Defense Agreement in Criminal Defense?
- Should DOJ Indict President Trump But Seal the Indictment?
- SEC Investigations 101: The Endgame
Categories
- Acquittal After Jury Trial
- Antitrust
- Appeal
- Attorney client privilege
- Bail
- Bank fraud
- Brady violations
- Bribery
- CFTC case
- Change Venue
- civil case
- Civil forfeiture
- Civil Litigation Strategy
- Classifiied information
- Commercial Bribery
- Compliance
- Computer fraud
- Congressional investigation
- Conspiracy
- Continuing education
- Conviction After Jury Trial
- Criminal Forfeiture
- Criminal Investigation
- Deferred Prosecution Agreement
- Dentention issues
- Detention issues
- Discovery/Brady
- Dismissal of charges in indictment
- DOJ policy and practice
- DOJ Statements
- Due Diligence
- Environmental Crimes
- Ethics
- False Claims Act
- False statements
- FBI policy and practice
- FCPA
- Federal program fraud
- Fifth Amendment
- First Amendment
- Fourth Amendment
- Fraud on the court
- Gag order
- Government contracting fraud
- Grand jury
- Grand Jury Subpoena
- Health care fraud
- Honest Services
- Identity Theft
- Immunity
- Indictment
- Insider Trading
- internal investigation
- International Trade Violations
- Investor fraud
- Joint Defense Agreements
- Jury issues
- Kickbacks
- Lacey Act
- Legal profession
- Mail Fraud
- Marketing
- Money Laundering
- Non-Prosecution Agreement
- Obstruction
- OIG investigations
- Perjury
- Plea Agreement
- Policy issues
- Pre-Trial Motions Practice
- Proffers
- Prosecutorial misconduct
- Public Corruption
- Research misconduct
- Resource Guide
- Restitution
- Reversal
- RICO
- Search warrant
- SEC Investigation
- SEC policy and practice
- SEC Settlement
- Securities fraud
- Sentencing
- Speedy Trial Act
- Statute of Limitations
- Tax fraud
- Trade Secrets
- Travel Act
- Trial preparation
- Trials
- Uncategorized
- Venue
- Wire Fraud
- Wiretaps
- Witness tampering
Archives
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
Tag Archives: Pharmaceutical industry; marketing industry
Corporate Kickback Charges That Involve Private Jets, A “Gentleman’s Club” and Marketing for Pharmaceutical Companies
Michael Mitrow, Jr. and his brother Matthew Mitrow were recently charged in a superseding indictment for a corporate kickback scheme in the Southern District of New York. The Brothers Mitrow were executives of an unnamed marketing agency. According to the … Continue reading
